75
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Pharmacodynamic enhancement of the anti-platelet antibody Fab abciximab by site-specific pegylation

, , , , , & show all
Pages 409-418 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Germaine Fuh. (2007) Synthetic antibodies as therapeutics. Expert Opinion on Biological Therapy 7:1, pages 73-87.
Read now

Articles from other publishers (17)

Moeka Yoshikawa, Hitomi Nakamura, Naoko Oda-Ueda & Takatoshi Ohkuri. (2023) Analysis of thermostability for seven Phe to Ala and six Pro to Gly mutants in the Fab constant region of adalimumab. The Journal of Biochemistry.
Crossref
Jong Shin, Paul J. Phelan, Ole Gjoerup, William Bachovchin & Peter A. Bullock. (2021) Characterization of a single chain variable fragment of nivolumab that targets PD-1 and blocks PD-L1 binding. Protein Expression and Purification 177, pages 105766.
Crossref
Hitomi Nakamura, Makoto Anraku, Naoko Oda-Ueda, Tadashi Ueda & Takatoshi Ohkuri. (2020) C-Terminal Cysteine PEGylation of Adalimumab Fab with an Engineered Interchain SS Bond. Biological and Pharmaceutical Bulletin 43:3, pages 418-423.
Crossref
Hitomi Nakamura, Naoko Oda-Ueda, Tadashi Ueda & Takatoshi Ohkuri. (2018) A novel engineered interchain disulfide bond in the constant region enhances the thermostability of adalimumab Fab. Biochemical and Biophysical Research Communications 495:1, pages 7-11.
Crossref
Maria Vamvakaki. 2014. Chemistry of Bioconjugates. Chemistry of Bioconjugates 203 238 .
Yasuto AKIYAMA, Haruo MIYATA, Masaru KOMIYAMA, Masahiro NOGAMI, Kazumichi OZAWA, Chie OSHITA, Akiko KUME, Tadashi ASHIZAWA, Naoki SAKURA, Tohru MOCHIZUKI & Ken YAMAGUCHI. (2014) The identification of affinity peptide ligands specific to the variable region ofhuman antibodies. Biomedical Research 35:2, pages 105-116.
Crossref
Salome-Juliette Koussoroplis, Sam Heywood, Catherine Uyttenhove, Céline Barilly, Jacques Van Snick & Rita Vanbever. (2013) Production, purification and biological characterization of mono-PEGylated anti-IL-17A antibody fragments. International Journal of Pharmaceutics 454:1, pages 107-115.
Crossref
Annabelle Patricia Herrington-Symes, Monika Farys, Hanieh Khalili & Steve Brocchini. (2013) Antibody fragments: Prolonging circulation half-life special issue-antibody research. Advances in Bioscience and Biotechnology 04:05, pages 689-698.
Crossref
R. Blake Pepinsky, Lee Walus, Zhaohui Shao, Benxiu Ji, Sheng Gu, Yaping Sun, Dingyi Wen, Xinhua Lee, Qin Wang, Ellen Garber & Sha Mi. (2011) Production of a PEGylated Fab′ of the anti-LINGO-1 Li33 Antibody and Assessment of Its Biochemical and Functional Properties in Vitro and in a Rat Model of Remyelination. Bioconjugate Chemistry 22:2, pages 200-210.
Crossref
Sam P. Heywood & David P. Humphreys. 2009. Recombinant Antibodies for Immunotherapy. Recombinant Antibodies for Immunotherapy 275 292 .
Aran F Labrijn, Rob C Aalberse & Janine Schuurman. (2008) When binding is enough: nonactivating antibody formats. Current Opinion in Immunology 20:4, pages 479-485.
Crossref
David Filpula. (2007) Antibody engineering and modification technologies. Biomolecular Engineering 24:2, pages 201-215.
Crossref
David P. Humphreys, Sam P. Heywood, Alistair Henry, Layla Ait-Lhadj, Pari Antoniw, Roger Palframan, Kevin J. Greenslade, Bruce Carrington, Dominc G. Reeks, Leigh C. Bowering, Shauna West & Helen A. Brand. (2007) Alternative antibody Fab′ fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineering. Protein Engineering, Design and Selection 20:5, pages 227-234.
Crossref
Hisashi Koga, Motoki Kyo, Kazue Usui-Aoki & Kazuki Inamori. (2006) A chip-based miniaturized format for protein-expression profiling: The exploitation of comprehensively produced antibodies. ELECTROPHORESIS 27:18, pages 3676-3683.
Crossref
Robert Mabry, Mridula Rani, Robert Geiger, Gene B. Hubbard, Ricardo CarrionJrJr, Kathleen Brasky, Jean L. Patterson, George Georgiou & B. L. Iverson. (2005) Passive Protection against Anthrax by Using a High-Affinity Antitoxin Antibody Fragment Lacking an Fc Region. Infection and Immunity 73:12, pages 8362-8368.
Crossref
Rebecca L. Rich & David G. Myszka. (2005) Survey of the year 2004 commercial optical biosensor literature. Journal of Molecular Recognition 18:6, pages 431-478.
Crossref
Philipp Holliger & Peter J Hudson. (2005) Engineered antibody fragments and the rise of single domains. Nature Biotechnology 23:9, pages 1126-1136.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.